Terkivatan T - Search Results

1

Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial.

Dols LF, Kok NF, Terkivatan T, Tran TC, d'Ancona FC, Langenhuijsen JF, zur Borg IR, Alwayn IP, Hendriks MP, Dooper IM, Weimar W, Ijzermans JN. Dols LF, et al. Among authors: terkivatan t. BMC Surg. 2010 Mar 25;10:11. doi: 10.1186/1471-2482-10-11. BMC Surg. 2010. PMID: 20338030 Free PMC article. Clinical Trial.

2

Treatment of ruptured hepatocellular adenoma.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, IJzermans JN. Terkivatan T, et al. Br J Surg. 2001 Feb;88(2):207-9. doi: 10.1046/j.1365-2168.2001.01648.x. Br J Surg. 2001. PMID: 11167868

3

Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJzermans JN. Terkivatan T, et al. Arch Surg. 2001 Sep;136(9):1033-8. doi: 10.1001/archsurg.136.9.1033. Arch Surg. 2001. PMID: 11529826

4

Transcatheter arterial embolization as a safe and effective treatment for focal nodular hyperplasia of the liver.

Terkivatan T, Hussain SM, Lameris JS, IJzermans JN. Terkivatan T, et al. Cardiovasc Intervent Radiol. 2002 Sep-Oct;25(5):450-3. doi: 10.1007/s00270-002-1929-6. Epub 2002 May 20. Cardiovasc Intervent Radiol. 2002. PMID: 12016523

5

Size of lesion is not a criterion for resection during management of giant liver haemangioma.

Terkivatan T, Vrijland WW, Den Hoed PT, De Man RA, Hussain SM, Tilanus HW, IJzermans JN. Terkivatan T, et al. Br J Surg. 2002 Oct;89(10):1240-4. doi: 10.1046/j.1365-2168.2002.02219.x. Br J Surg. 2002. PMID: 12296890

6

Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.

Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA. Hussain SM, et al. Among authors: terkivatan t. Radiographics. 2004 Jan-Feb;24(1):3-17; discussion 18-9. doi: 10.1148/rg.241035050. Radiographics. 2004. PMID: 14730031 Review.

7

Diagnosis and treatment of benign focal liver lesions.

Terkivatan T, Hussain SM, De Man RA, Ijzermans JN. Terkivatan T, et al. Scand J Gastroenterol Suppl. 2006;(243):102-15. doi: 10.1080/00365520600664391. Scand J Gastroenterol Suppl. 2006. PMID: 16782629 Review.

8

Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.

Terkivatan T, van den Bos IC, Hussain SM, Wielopolski PA, de Man RA, IJzermans JN. Terkivatan T, et al. J Magn Reson Imaging. 2006 Oct;24(4):864-72. doi: 10.1002/jmri.20705. J Magn Reson Imaging. 2006. PMID: 16947339

9

Regarding 'Liver cell adenoma and liver cell adenomatosis' by Ludger Barthelmes and Iain S. Tait.

Kok NF, Terkivatan T, Ijzermans JN. Kok NF, et al. Among authors: terkivatan t. HPB (Oxford). 2006;8(1):71-2. doi: 10.1080/13651820500537879. HPB (Oxford). 2006. PMID: 18333245 Free PMC article. No abstract available.

10

Hepatocellular adenoma: cost-effectiveness of different treatment strategies.

van der Sluis FJ, Bosch JL, Terkivatan T, de Man RA, Ijzermans JN, Hunink MG. van der Sluis FJ, et al. Among authors: terkivatan t. Radiology. 2009 Sep;252(3):737-46. doi: 10.1148/radiol.2523082219. Radiology. 2009. PMID: 19717753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page